These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24215894)

  • 41. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PAK thread from amoeba to mammals.
    Kumar A; Molli PR; Pakala SB; Bui Nguyen TM; Rayala SK; Kumar R
    J Cell Biochem; 2009 Jul; 107(4):579-85. PubMed ID: 19350548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain.
    Kim DJ; Choi CK; Lee CS; Park MH; Tian X; Kim ND; Lee KI; Choi JK; Ahn JH; Shin EY; Shin I; Kim EG
    Exp Mol Med; 2016 Apr; 48(4):e229. PubMed ID: 27126178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The emerging importance of group II PAKs.
    Wells CM; Jones GE
    Biochem J; 2010 Jan; 425(3):465-73. PubMed ID: 20070256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.
    Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X
    Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders.
    Zhang K; Wang Y; Fan T; Zeng C; Sun ZS
    Protein Cell; 2022 Jan; 13(1):6-25. PubMed ID: 33306168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
    Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
    Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p120-catenin is a binding partner and substrate for Group B Pak kinases.
    Wong LE; Reynolds AB; Dissanayaka NT; Minden A
    J Cell Biochem; 2010 Aug; 110(5):1244-54. PubMed ID: 20564219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Group I and II mammalian PAKs have different modes of activation by Cdc42.
    Baskaran Y; Ng YW; Selamat W; Ling FT; Manser E
    EMBO Rep; 2012 Jun; 13(7):653-9. PubMed ID: 22653441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of p21-activated kinases in pancreatic cancer.
    Yeo D; He H; Baldwin GS; Nikfarjam M
    Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p21-activated kinase signaling in breast cancer.
    Gururaj AE; Rayala SK; Kumar R
    Breast Cancer Res; 2005; 7(1):5-12. PubMed ID: 15642175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PAKs in the brain: Function and dysfunction.
    Civiero L; Greggio E
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):444-453. PubMed ID: 29129728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PAK2 activated by Cdc42 and caspase 3 mediates different cellular responses to oxidative stress-induced apoptosis.
    Huang J; Huang A; Poplawski A; DiPino F; Traugh JA; Ling J
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118645. PubMed ID: 31926209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Group I p21-activated kinases: emerging roles in immune function and viral pathogenesis.
    Pacheco A; Chernoff J
    Int J Biochem Cell Biol; 2010 Jan; 42(1):13-6. PubMed ID: 19747561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAK signaling in oncogenesis.
    Molli PR; Li DQ; Murray BW; Rayala SK; Kumar R
    Oncogene; 2009 Jul; 28(28):2545-55. PubMed ID: 19465939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p21-Activated kinases as promising therapeutic targets in hematological malignancies.
    Wu A; Jiang X
    Leukemia; 2022 Feb; 36(2):315-326. PubMed ID: 34697424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P21-activated kinases in human cancer.
    Vadlamudi RK; Kumar R
    Cancer Metastasis Rev; 2003 Dec; 22(4):385-93. PubMed ID: 12884913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAK5 is auto-activated by a central domain that promotes kinase oligomerization.
    Tabanifar B; Zhao Z; Manser E
    Biochem J; 2016 Jun; 473(12):1777-89. PubMed ID: 27095851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.